BioLife Sciences Inc. (OTCPK: BLFE) launches BioLife Copper-Infused Microfiber Towels, copper variations of traditional microfiber towels, designed to outlast competitors’ standard microfiber towel production due to copper’s ability to limit bacteria reproduction.
BioLife’s additional copper-infused products, including the BioLife Copper-Infused Fabric Pot and the BioLife Copper-Infused Gardening Gloves.
BioLife achieves copper infusion in textiles by utilizing MFusion – a process which infuses copper metal ions directly into every sub-bundle of the fabric, providing extensive copper coverage throughout the textile. MFusion also leverages the natural antimicrobial benefits of copper ions, which have been shown to kill 99.99% of harmful bacteria and viruses.
Earlier on in the week on Tuesday, BioLife Sciences Inc had come into the news cycle after the company made a major news announcement. Before the start of the trading day today, it could be a good idea for investors to consider taking a look into it. On that day the company announces that it had launched BioLife Copper-Infused Microfiber Towels.
The announcement of the launch of a new product is almost always regarded as a major new development for any company. The latest launch is part of BioLife Sciences’ thrust towards the creation of a wide range of copper-infused products. It was also pointed out that the BioLife Copper-Infused Microfiber Towels are actually a variation of the regular microfiber towels that are already available in the market.
The product in question has some unique advantages when compared to traditional microfiber towels. It is a product that is expected to outlast the traditional towels for the simple reason that copper has the capability of limiting reproduction of bacteria. The design of the BioLife Copper-Infused Microfiber Towels is also unique. It emits an electrostatic charge which helps it in attracting even the tiniest bit of dust. The product could well prove to be a major addition to the range of copper infused products from BioLife and it remains to be seen if it has a bearing on the company’s stock price or not.